Publications

Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma

Download PDF
Resource: Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma

.

Related Articles

In vivo interaction screening reveals liver-derived constraints to metastasis

Link
Morphology-Aware Profiling of Highly Multiplexed Tissue Images using Variational Autoencoders

Link